Probiotics and medical nutrition therapy - PubMed (original) (raw)
Review
. 2004 Apr-Jun;7(2):56-68.
Affiliations
- PMID: 15481739
- PMCID: PMC1482314
Review
Probiotics and medical nutrition therapy
Amy C Brown et al. Nutr Clin Care. 2004 Apr-Jun.
Abstract
Probiotics have been defined by The Food Agricultural Organization/World Health Organization (FAO/WHO) as "live microorganisms which when administered in adequate amounts confer a health benefit to the host." They have been used for centuries in the form of dairy-based fermented products, but the potential use of probiotics as a form of medical nutrition therapy has not received formal recognition. A detailed literature review (from 1950 through February 2004) of English-language articles was undertaken to find articles showing a relationship between probiotic use and medical conditions. Medical conditions that have been reportedly treated or have the potential to be treated with probiotics include diarrhea, gastroenteritis, irritable bowel syndrome, and inflammatory bowel disease (Crohn's disease and ulcerative colitis), cancer, depressed immune function, inadequate lactase digestion, infant allergies, failure-to-thrive, hyperlipidemia, hepatic diseases, Helicobacter pylori infections, genitourinary tract infections, and others. The use of probiotics should be further investigated for possible benefits and side-effects in patients affected by these medical conditions.
Similar articles
- Review article: Probiotics in gastrointestinal and liver diseases.
Jonkers D, Stockbrügger R. Jonkers D, et al. Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:133-48. doi: 10.1111/j.1365-2036.2007.03480.x. Aliment Pharmacol Ther. 2007. PMID: 18081657 Review. - Probiotics as an alternative strategy for prevention and treatment of human diseases: a review.
Khani S, Hosseini HM, Taheri M, Nourani MR, Imani Fooladi AA. Khani S, et al. Inflamm Allergy Drug Targets. 2012 Apr;11(2):79-89. doi: 10.2174/187152812800392832. Inflamm Allergy Drug Targets. 2012. PMID: 22280243 Review. - Probiotics. Some evidence of their effectiveness.
Reid G, Hammond JA. Reid G, et al. Can Fam Physician. 2005 Nov;51(11):1487-93. Can Fam Physician. 2005. PMID: 16353831 Free PMC article. Review. - The medicinal uses of poi.
Brown AC, Valiere A. Brown AC, et al. Nutr Clin Care. 2004 Apr-Jun;7(2):69-74. Nutr Clin Care. 2004. PMID: 15481740 Free PMC article. Review. - Probiotics: facts and myths.
Senok AC, Ismaeel AY, Botta GA. Senok AC, et al. Clin Microbiol Infect. 2005 Dec;11(12):958-66. doi: 10.1111/j.1469-0691.2005.01228.x. Clin Microbiol Infect. 2005. PMID: 16307549 Review.
Cited by
- Potential probiotic Lactiplantibacillus plantarum strains alleviate TNF-α by regulating ADAM17 protein and ameliorate gut integrity through tight junction protein expression in in vitro model.
Devi MB, Bhattacharya A, Kumar A, Singh CT, Das S, Sarma HK, Mukherjee AK, Khan MR. Devi MB, et al. Cell Commun Signal. 2024 Oct 28;22(1):520. doi: 10.1186/s12964-024-01900-7. Cell Commun Signal. 2024. PMID: 39468700 Free PMC article. - Overview of the Efficacy of Using Probiotics for Neurosurgical and Potential Neurosurgical Patients.
Fijan S, Šmigoc T. Fijan S, et al. Microorganisms. 2024 Jul 2;12(7):1361. doi: 10.3390/microorganisms12071361. Microorganisms. 2024. PMID: 39065129 Free PMC article. Review. - A Comparison of Outcomes from Antibiotic Treatment with and without Probiotics in 897 Patients with Lower Urogenital Tract Infections, Including Cystitis, Urethritis, Prostatitis, and Vulvovaginitis.
Mula D, Dervishi R, Hoxha R, Dervishi L, Gashi MM, Muçaj S, Muçaj E, Kuçi L. Mula D, et al. Med Sci Monit Basic Res. 2024 Jun 26;30:e943939. doi: 10.12659/MSMBR.943939. Med Sci Monit Basic Res. 2024. PMID: 38918937 Free PMC article. - Effect of probiotics plus zinc supplementation on clinical outcomes of infants and children with acute infectious diarrhea: a randomized controlled trial.
Abdulah DM, Sulaiman SJ, Ahmed ZW. Abdulah DM, et al. Clin Exp Pediatr. 2024 Apr;67(4):203-212. doi: 10.3345/cep.2023.01340. Epub 2024 Feb 19. Clin Exp Pediatr. 2024. PMID: 38374706 Free PMC article. - Gut-immune axis and cardiovascular risk in chronic kidney disease.
Behrens F, Bartolomaeus H, Wilck N, Holle J. Behrens F, et al. Clin Kidney J. 2023 Dec 13;17(1):sfad303. doi: 10.1093/ckj/sfad303. eCollection 2024 Jan. Clin Kidney J. 2023. PMID: 38229879 Free PMC article. Review.
References
- Marteau PR, de Vrese M, Cellier CJ, Schrezenmeir J. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr. 2001;73(suppl 2):430S–436S. - PubMed
- Gismondo MR, Drago L, Lombardi A. Review of probiotics available to modify gastrointestinal flora. Int J Antimicrob Agents. 1999;12:287–292. - PubMed
- Salminen S, Isolauri E, Onnela T. Gut microflora in normal and disordered states. Chemotherapy. 1995;41(suppl 1):5–15. - PubMed
- Salminen S. Lactic acid bacteria in health and disease. Lactic Acid Bacteria: Microbiology and Functional Aspects. 2nd ed. New York: Marcel Dekker; 1998:211–254.
Publication types
MeSH terms
Grants and funding
- P20 RR011091/RR/NCRR NIH HHS/United States
- P20 RR011091-100026/RR/NCRR NIH HHS/United States
- P20 RR011091-11/RR/NCRR NIH HHS/United States
- P20 RR11091/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources